|
Search for Healthcare Articles
by Biomedical Industries
Biotechnology
Zapping microbes with lasers and enzymes-Interactive tool
Fighting the rise of drug-resistant bacteria
Date:
07/28/2008
, Publication:
MSNBC
, Author:
Bryn Nelson
http://www.msnbc.msn.com/id/25838831/
Zapping microbes with lasers and enzymes
New tools could help fight the growing ranks of antibiotic-resistant bacteria
Date:
07/28/2008
, Publication:
MSNBC
, Author:
Bryn Nelson
http://www.msnbc.msn.com/id/25838829/
Health Plan From Obama Spurs Debate
It is one of the most audacious promises in a campaign that has been thick with them.
Date:
07/23/2008
, Publication:
NY TIMES
, Author:
KEVIN SACK
http://www.nytimes.com/2008/07/23/us/23health.html?ref=health
FDA Rule and Companion Guidance Make Early Stage Clinical Drug Development Safe and EfficientDate:
07/19/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01863.html
While the U.S. Spends Heavily on Health Care, a Study Faults the Quality
But it has fallen to last place among those countries in preventing deaths through use of timely and effective medical care...
Date:
07/17/2008
, Publication:
NY TIMES
, Author:
REED ABELSON
http://www.nytimes.com/2008/07/17/business/17health.html?ref=health
VIDEO-DNA ZoomDate:
07/16/2008
, Publication:
Nucleus Medical Arts
, Author:
Nucleus Medical Arts
http://catalog.nucleusinc.com/generateexhibit.php?ID=26541&ExhibitKeywordsRaw=&
VIDEO-DNA HelixDate:
07/16/2008
, Publication:
Nucleus Medical Arts
, Author:
Nucleus Medical Arts
http://catalog.nucleusinc.com/generateexhibit.php?ID=26577&ExhibitKeywordsRaw=&
FDA Revises Process for Responding to Drug Applications
The U.S. Food and Drug Administration today announced that it is revising the way it communicates to drug companies when a marketing application cannot be approved as submitted.
Date:
07/09/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01859.html
Breast Cancer: FDA Approves New Genetic Test for Patients with Breast Cancer
The U.S. Food and Drug Administration has approved a novel genetic test for determining whether patients with breast cancer are good candidates for treatment with the drug Herceptin (trastuzumab).
Date:
07/08/2008
, Publication:
FDA News
, Author:
FDA
http://www.fda.gov/bbs/topics/NEWS/2008/NEW01857.html
VIDEO-Cancer-Tumor Targeting and Gene Delivery-Scene 1
Rexen-G Mechanism of Action
Date:
07/01/2008
, Publication:
Hybrid Medical Animation
, Author:
Hybrid Medical Animation
http://www.hybridmedicalanimation.com/anim_rexg3.html
< Previous
Page 2 of 38
Next >
Search returned 378 items.
|
Sponsored Links
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
This twice-monthly news magazine
reports on all phases of pharmacy
www.drugtopics.com
|